{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:17:00Z","timestamp":1791267420514,"version":"4.1.0"},"reference-count":92,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2020,11,26]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Parkinson\u2019s Disease (PD) is characterized by both motor and non-motor\nsymptoms. The presynaptic neuronal protein, \u03b1-Synuclein, plays a pivotal role in PD pathogenesis and\nis associated with both genetic and sporadic origin of the disease. Ursolic Acid (UA) is a well-known\nbioactive compound found in various medicinal plants, widely studied for its anti-inflammatory and\nantioxidant activities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this research article, the neuroprotective potential of UA has been further explored in the\nRotenone-induced mouse model of PD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>To investigate our hypothesis, we have divided mice into 4 different groups, control, drug\nonly control, Rotenone-intoxicated group, and Rotenone-intoxicated mice treated with UA. After the\ncompletion of dosing, behavioral parameters were estimated. Then mice from each group were sacrificed\nand the brains were isolated. Further, the biochemical tests were assayed to check the balance\nbetween the oxidative stress and endogenous anti-oxidants; and TH (Tyrosine Hydroxylase),\n\u03b1-Synuclein, Akt (Serine-threonine protein kinase), ERK (Extracellular signal-regulated kinase) and\ninflammatory parameters like Nuclear Factor-\u03baB (NF-\u03baB) and Tumor Necrosis Factor- \u03b1 (TNF-\u03b1) were\nassessed using Immunohistochemistry (IHC). Western blotting was also done to check the expressions\nof TH and \u03b1-Synuclein. Moreover, the expression levels of PD related genes like \u03b1-Synuclein,\n\u03b2-Synuclein, Interleukin-1\u03b2 (IL-1\u03b2), and Interleukin-10 (IL-10) were assessed by using Real-time\nPCR.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results obtained in our study suggested that UA significantly reduced the overexpression\nof \u03b1-Synuclein and regulated the phosphorylation of survival-related kinases (Akt and ERK) apart\nfrom alleviating the behavioral abnormalities and protecting the dopaminergic neurons from oxidative\nstress and neuroinflammation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Thus, our study shows the neuroprotective potential of UA, which can further be explored\nfor possible clinical intervention.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527319666200812224457","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T12:11:58Z","timestamp":1597320718000},"page":"527-540","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model"],"prefix":"10.2174","volume":"19","author":[{"given":"Walia","family":"Zahra","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachchida Nand","family":"Rai","sequence":"additional","affiliation":[{"name":"Centre of Biotechnology, University of Allahabad, Prayagraj-211002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hareram","family":"Birla","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra Sen","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaina Singh","family":"Rathore","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagera","family":"Dilnashin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Keswani","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya Pratap","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mrfmmm.2008.10.011","volume":"667","author":"Migliore L.","year":"2009","unstructured":"Migliore L.; Copped\u00e8 F.; Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 2009,667(1-2),82-97","journal-title":"Mutat Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"Auluck P.K.","year":"2002","unstructured":"Auluck P.K.; Chan H.Y.; Trojanowski J.Q.; Lee V.M.; Bonini N.M.; Chaperone suppression of \u03b1-synuclein toxicity in a Drosophila model for Parkinson\u2019s disease. Science 2002,295(5556),865-868","journal-title":"Science"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"Feany M.B.","year":"2000","unstructured":"Feany M.B.; Bender W.W.; A Drosophila model of Parkinson\u2019s disease. Nature 2000,404(6776),394-398","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"Masliah E.","year":"2000","unstructured":"Masliah E.; Rockenstein E.; Veinbergs I.; Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000,287(5456),1265-1269","journal-title":"Science"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/891748","volume":"2013","author":"Bhullar K.S.","year":"2013","unstructured":"Bhullar K.S.; Rupasinghe H.P.; Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid Med Cell Longev 2013,2013","journal-title":"Oxid Med Cell Longev"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pr.113.007757","volume":"66","author":"Lee J.","year":"2014","unstructured":"Lee J.; Jo D.G.; Park D.; Chung H.Y.; Mattson M.P.; Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system. Pharmacol Rev 2014,66(3),815-868","journal-title":"Pharmacol Rev"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnmol.2014.00057","volume":"7","author":"Dzamko N.","year":"2014","unstructured":"Dzamko N.; Zhou J.; Huang Y.; Halliday G.M.; Parkinson\u2019s disease-implicated kinases in the brain; insights into disease pathogenesis. Front Mol Neurosci 2014,7,57","journal-title":"Front Mol Neurosci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.taap.2017.01.019","volume":"319","author":"Cao Q.","year":"2017","unstructured":"Cao Q.; Qin L.; Huang F.; Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson\u2019s disease model mice through PI3K\/Akt and ERK signaling pathways. Toxicol Appl Pharmacol 2017,319,80-90","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuint.2012.10.014","volume":"62","author":"Cheng B.","year":"2013","unstructured":"Cheng B.; Martinez A.A.; Morado J.; Scofield V.; Roberts J.L.; Maffi S.K.; Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway. Neurochem Int 2013,62(1),31-42","journal-title":"Neurochem Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.phymed.2016.12.017","volume":"25","author":"Chen W.F.","year":"2017","unstructured":"Chen W.F.; Wu L.; Du Z.R.; Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson\u2019s disease: involvement of PI3K\/Akt and MEK\/ERK signaling pathways. Phytomedicine 2017,25,93-99","journal-title":"Phytomedicine"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"Rai S.N.","year":"2019","unstructured":"Rai S.N.; Dilnashin H.; Birla H.; The role of PI3K\/Akt and ERK in neurodegenerative disorders. Neurotox Res 2019,35(3),775-795","journal-title":"Neurotox Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1046\/j.1471-4159.2003.01791.x","volume":"85","author":"Hashimoto M.","year":"2003","unstructured":"Hashimoto M.; Takenouchi T.; Rockenstein E.; Masliah E.; \u03b1-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson\u2019s disease. J Neurochem 2003,85(6),1468-1479","journal-title":"J Neurochem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"23622","DOI":"10.1074\/jbc.M313784200","volume":"279","author":"Hashimoto M.","year":"2004","unstructured":"Hashimoto M.; Bar-On P.; Ho G.; \u03b2-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson\u2019s disease. J Biol Chem 2004,279(22),23622-23629","journal-title":"J Biol Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"45320","DOI":"10.1074\/jbc.M103736200","volume":"276","author":"Iwata A.","year":"2001","unstructured":"Iwata A.; Maruyama M.; Kanazawa I.; Nukina N.; \u03b1-Synuclein affects the MAPK pathway and accelerates cell death. J Biol Chem 2001,276(48),45320-45329","journal-title":"J Biol Chem"},{"key":"ref=15","first-page":"5499","volume":"9","author":"Ojha S.","year":"2015","unstructured":"Ojha S.; Javed H.; Azimullah S.; Abul Khair S.B.; Haque M.E.; Neuroprotective potential of ferulic acid in the rotenone model of Parkinson\u2019s disease. Drug Des Devel Ther 2015,9,5499-5510","journal-title":"Drug Des Devel Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainres.2016.11.020","volume":"1655","author":"Zhang Z.N.","year":"2017","unstructured":"Zhang Z.N.; Zhang J.S.; Xiang J.; Subcutaneous rotenone rat model of Parkinson\u2019s disease: dose exploration study. Brain Res 2017,1655,104-113","journal-title":"Brain Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12017-018-08521-7","volume":"21","author":"Birla H.","year":"2019","unstructured":"Birla H.; Rai S.N.; Singh S.S.; Tinospora cordifolia suppresses neuroinflammation in parkinsonian mouse model. Neuromolecular Med 2019,21(1),42-53","journal-title":"Neuromolecular Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.freeradbiomed.2010.06.002","volume":"49","author":"Fukui M.","year":"2010","unstructured":"Fukui M.; Choi H.J.; Zhu B.T.; Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med 2010,49(5),800-813","journal-title":"Free Radic Biol Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5958\/0975-6892.2017.00001.6","volume":"9","author":"Keswani C.","year":"2017","unstructured":"Keswani C.; Bisen K.; Singh S.P.; Singh H.B.; Traditional knowledge and medicinal plants of India in intellectual property landscape. Medicinal Plants-International Journal of Phytomedicines and Related Industries 2017,9(1),1-1","journal-title":"Medicinal Plants-International Journal of Phytomedicines and Related Industries"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jchemneu.2017.06.005","volume":"85","author":"Rai S.N.","year":"2017","unstructured":"Rai S.N.; Birla H.; Zahra W.; Singh S.S.; Singh S.P.; Immunomodulation of Parkinson\u2019s disease using Mucuna pruriens (Mp). J Chem Neuroanat 2017,85,27-35","journal-title":"J Chem Neuroanat"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fnagi.2017.00421","volume":"9","author":"Rai S.N.","year":"2017","unstructured":"Rai S.N.; Birla H.; Singh S.S.; Mucuna pruriens protects against MPTP Intoxicated Neuroinflammation in Parkinson\u2019s disease through NF-\u03baB\/pAKT signaling pathways. Front Aging Neurosci 2017,9,421","journal-title":"Front Aging Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12993-019-0160-4","volume":"15","author":"Birla H.","year":"2019","unstructured":"Birla H.; Keswani C.; Rai S.N.; Neuroprotective effects of Withania somnifera in BPA induced-cognitive dysfunction and oxidative stress in mice. Behav Brain Funct 2019,15(1),9","journal-title":"Behav Brain Funct"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6571484","volume":"2020","author":"Singh S.S.","year":"2020","unstructured":"Singh S.S.; Rai S.N.; Birla H.; Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of da neurons in a parkinsonian mouse model. Oxid Med Cell Longev 2020,2020","journal-title":"Oxid Med Cell Longev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","volume":"49","author":"Liu J.","year":"1995","unstructured":"Liu J.; Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995,49(2),57-68","journal-title":"J Ethnopharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1002\/mnfr.200700433","volume":"52","author":"Neto C.C.","year":"2008","unstructured":"Neto C.C.; Amoroso J.W.; Liberty A.M.; Anticancer activities of cranberry phytochemicals: an update. Mol Nutr Food Res 2008,52(S1)(Suppl. 1),S18-S27","journal-title":"Mol Nutr Food Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1248\/jhs.54.654","volume":"54","author":"Yamaguchi H.","year":"2008","unstructured":"Yamaguchi H.; Noshita T.; Kidachi Y.; Isolation of ursolic acid from apple peels and its specific efficacy as a potent antitumor agent. J Health Sci 2008,54(6),654-660","journal-title":"J Health Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","volume":"71","author":"Rai S.N.","year":"2016","unstructured":"Rai S.N.; Yadav S.K.; Singh D.; Singh S.P.; Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 2016,71,41-49","journal-title":"J Chem Neuroanat"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8512048","volume":"2019","author":"Habtemariam S.","year":"2019","unstructured":"Habtemariam S.; Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression. Oxid Med Cell Longev 2019,2019","journal-title":"Oxid Med Cell Longev"},{"key":"ref=29","first-page":"3299","volume":"8","author":"Zhu Z.","year":"2016","unstructured":"Zhu Z.; Du S.; Ding F.; Guo S.; Ying G.; Yan Z.; Ursolic acid attenuates temozolomide resistance in glioblastoma cells by downregulating O(6)-methylguanine-DNA methyltransferase (MGMT) expression. Am J Transl Res 2016,8(7),3299-3308","journal-title":"Am J Transl Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/cercor\/bhq002","volume":"20","author":"Lu J.","year":"2010","unstructured":"Lu J.; Wu D.M.; Zheng Y.L.; Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs\/RAGE\/NF-\u03baB pathway activation. Cereb Cortex 2010,20(11),2540-2548","journal-title":"Cereb Cortex"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nlm.2011.03.010","volume":"96","author":"Wang Y.J.","year":"2011","unstructured":"Wang Y.J.; Lu J.; Wu D.M.; Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38\/NF-\u03baB mediated inflammatory pathways. Neurobiol Learn Mem 2011,96(2),156-165","journal-title":"Neurobiol Learn Mem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4142\/jvs.2006.7.2.133","volume":"7","author":"Manna S.","year":"2006","unstructured":"Manna S.; Bhattacharyya D.; Mandal T.K.; Dey S.; Neuropharmacological effects of deltamethrin in rats. J Vet Sci 2006,7(2),133-136","journal-title":"J Vet Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0278-5846(88)90038-3","volume":"12","author":"Pisa M.","year":"1988","unstructured":"Pisa M.; Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism. Prog Neuropsychopharmacol Biol Psychiatry 1988,12(2-3),217-224","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jns.2006.06.018","volume":"249","author":"Mohanasundari M.","year":"2006","unstructured":"Mohanasundari M.; Srinivasan M.S.; Sethupathy S.; Sabesan M.; Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice. J Neurol Sci 2006,249(2),140-144","journal-title":"J Neurol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3109\/10715762.2010.492832","volume":"44","author":"Kumar A.","year":"2010","unstructured":"Kumar A.; Ahmad I.; Shukla S.; Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 2010,44(8),950-965","journal-title":"Free Radic Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"Ohkawa H.","year":"1979","unstructured":"Ohkawa H.; Ohishi N.; Yagi K.; Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979,95(2),351-358","journal-title":"Anal Biochem"},{"key":"ref=37","first-page":"62","volume":"5","author":"Miranda K.M.","year":"2001","unstructured":"Miranda K.M.; Espey M.G.; Wink D.A.; A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide -. Biol Chem 2001,5(1),62-71","journal-title":"Biol Chem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"Moron M.S.","year":"1979","unstructured":"Moron M.S.; Depierre J.W.; Mannervik B.; Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979,582(1),67-78","journal-title":"Biochim Biophys Acta"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"Misra H.P.","year":"1972","unstructured":"Misra H.P.; Fridovich I.; The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972,247(10),3170-3175","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1073\/pnas.0711053105","volume":"105","author":"Gorbatyuk O.S.","year":"2008","unstructured":"Gorbatyuk O.S.; Li S.; Sullivan L.F.; The phosphorylation state of Ser-129 in human \u03b1-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc Natl Acad Sci USA 2008,105(2),763-768","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2172-5-3","volume":"5","author":"Peinnequin A.","year":"2004","unstructured":"Peinnequin A.; Mouret C.; Birot O.; Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004,5(1),3","journal-title":"BMC Immunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s11064-010-0176-5","volume":"35","author":"Gupta S.P.","year":"2010","unstructured":"Gupta S.P.; Patel S.; Yadav S.; Singh A.K.; Singh S.; Singh M.P.; Involvement of nitric oxide in maneb- and paraquat-induced Parkinson\u2019s disease phenotype in mouse: is there any link with lipid peroxidation? Neurochem Res 2010,35(8),1206-1213","journal-title":"Neurochem Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","volume":"4","author":"Normando E.M.","year":"2016","unstructured":"Normando E.M.; Davis B.M.; De Groef L.; The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson\u2019s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain. Acta Neuropathol Commun 2016,4(1),86","journal-title":"Acta Neuropathol Commun"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","volume":"269","author":"Anusha C.","year":"2017","unstructured":"Anusha C.; Sumathi T.; Joseph L.D.; Protective role of apigenin on rotenone induced rat model of Parkinson\u2019s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. Chem Biol Interact 2017,269,67-79","journal-title":"Chem Biol Interact"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/ar.23781","volume":"301","author":"Wang H.","year":"2018","unstructured":"Wang H.; Dong X.; Liu Z.; Resveratrol suppresses rotenone\u2010induced neurotoxicity through activation of SIRT1\/Akt1 signaling pathway. Anat Rec (Hoboken) 2018,301(6),1115-1125","journal-title":"Anat Rec (Hoboken)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","volume":"26","author":"Xu Y.","year":"2014","unstructured":"Xu Y.; Liu C.; Chen S.; Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease. Cell Signal 2014,26(8),1680-1689","journal-title":"Cell Signal"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3390\/toxins7093715","volume":"7","author":"Jung S.Y.","year":"2015","unstructured":"Jung S.Y.; Lee K.W.; Choi S.M.; Yang E.J.; Bee venom protects against rotenone-induced cell death in NSC34 motor neuron cells. Toxins 2015,7(9),3715-3726","journal-title":"Toxins"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-8546-7-1","volume":"7","author":"Song J.X.","year":"2012","unstructured":"Song J.X.; Choi M.Y.; Wong K.C.; Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism. Chin Med 2012,7(1),1-9","journal-title":"Chin Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3892\/etm.2017.4965","volume":"14","author":"Luo J.","year":"2017","unstructured":"Luo J.; Hu Y.L.; Wang H.; Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K\/AKT and NF-\u03baB signaling pathways in vitro. Exp Ther Med 2017,14(4),3623-3631","journal-title":"Exp Ther Med"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/419343","volume":"2011","author":"Wang X.","year":"2011","unstructured":"Wang X.; Zhang F.; Yang L.; Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol 2011,2011","journal-title":"J Biomed Biotechnol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2147\/DDDT.S103829","volume":"10","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; He Z.; Deng S.; Ursolic acid reduces the metalloprotease\/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury. Drug Des Devel Ther 2016,10,1663-1674","journal-title":"Drug Des Devel Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.pbb.2012.08.016","volume":"103","author":"Machado D.G.","year":"2012","unstructured":"Machado D.G.; Neis V.B.; Balen G.O.; Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: evidence for the involvement of the dopaminergic system. Pharmacol Biochem Behav 2012,103(2),204-211","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.brainres.2012.12.032","volume":"1497","author":"Li L.","year":"2013","unstructured":"Li L.; Zhang X.; Cui L.; Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res 2013,1497,32-39","journal-title":"Brain Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"34914","DOI":"10.1074\/jbc.M111.232116","volume":"286","author":"Wilkinson K.","year":"2011","unstructured":"Wilkinson K.; Boyd J.D.; Glicksman M.; Moore K.J.; El Khoury J.; A high content drug screen identifies ursolic acid as an inhibitor of amyloid \u03b2 protein interactions with its receptor CD36. J Biol Chem 2011,286(40),34914-34922","journal-title":"J Biol Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.brainresbull.2005.02.022","volume":"65","author":"Fornai F.","year":"2005","unstructured":"Fornai F.; Lenzi P.; Ferrucci M.; Occurrence of neuronal inclusions combined with increased nigral expression of \u03b1-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. Brain Res Bull 2005,65(5),405-413","journal-title":"Brain Res Bull"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","volume":"11","author":"Kowall N.W.","year":"2000","unstructured":"Kowall N.W.; Hantraye P.; Brouillet E.; Beal M.F.; McKee A.C.; Ferrante R.J.; MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 2000,11(1),211-213","journal-title":"Neuroreport"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1586\/14737175.7.12.1693","volume":"7","author":"Di Napoli M.","year":"2007","unstructured":"Di Napoli M.; Shah I.M.; Stewart D.A.; Molecular pathways and genetic aspects of Parkinson\u2019s disease: from bench to bedside. Expert Rev Neurother 2007,7(12),1693-1729","journal-title":"Expert Rev Neurother"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"Singh R.","year":"2009","unstructured":"Singh R.; Kaushik S.; Wang Y.; Autophagy regulates lipid metabolism. Nature 2009,458(7242),1131-1135","journal-title":"Nature"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3164\/jcbn.14-10","volume":"54","author":"Shichiri M.","year":"2014","unstructured":"Shichiri M.; The role of lipid peroxidation in neurological disorders. J Clin Biochem Nutr 2014,54(3),151-160","journal-title":"J Clin Biochem Nutr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0014-5793(94)00424-2","volume":"345","author":"Cleeter M.W.","year":"1994","unstructured":"Cleeter M.W.; Cooper J.M.; Darley-Usmar V.M.; Moncada S.; Schapira A.H.; Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994,345(1),50-54","journal-title":"FEBS Lett"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12640-013-9415-2","volume":"25","author":"Friend D.M.","year":"2014","unstructured":"Friend D.M.; Fricks-Gleason A.N.; Keefe K.A.; Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration? Neurotox Res 2014,25(2),153-160","journal-title":"Neurotox Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","volume":"74","author":"Tapias V.","year":"2017","unstructured":"Tapias V.; Hu X.; Luk K.C.; Sanders L.H.; Lee V.M.; Greenamyre J.T.; Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Cell Mol Life Sci 2017,74(15),2851-2874","journal-title":"Cell Mol Life Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","volume":"15","author":"Sutachan J.J.","year":"2012","unstructured":"Sutachan J.J.; Casas Z.; Albarracin S.L.; Cellular and molecular mechanisms of antioxidants in Parkinson\u2019s disease. Nutr Neurosci 2012,15(3),120-126","journal-title":"Nutr Neurosci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12035-013-8554-z","volume":"49","author":"Anderson G.","year":"2014","unstructured":"Anderson G.; Maes M.; Neurodegeneration in Parkinson\u2019s disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol 2014,49(2),771-783","journal-title":"Mol Neurobiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/bph.12433","volume":"171","author":"Celardo I.","year":"2014","unstructured":"Celardo I.; Martins L.M.; Gandhi S.; Unravelling mitochondrial pathways to Parkinson\u2019s disease. Br J Pharmacol 2014,171(8),1943-1957","journal-title":"Br J Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0047-6374(90)90078-T","volume":"51","author":"Pigeolet E.","year":"1990","unstructured":"Pigeolet E.; Corbisier P.; Houbion A.; Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990,51(3),283-297","journal-title":"Mech Ageing Dev"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-010-9523-y","volume":"30","author":"Yuan Y.","year":"2010","unstructured":"Yuan Y.; Sun J.; Zhao M.; Overexpression of \u03b1-synuclein down-regulates BDNF expression. Cell Mol Neurobiol 2010,30(6),939-946","journal-title":"Cell Mol Neurobiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11481-018-9824-3","volume":"14","author":"Muhammad T.","year":"2019","unstructured":"Muhammad T.; Ali T.; Ikram M.; Khan A.; Alam S.I.; Kim M.O.; Melatonin rescue oxidative stress-mediated neuroinflammation\/neurodegeneration and memory impairment in scopolamine-induced amnesia mice model. J Neuroimmune Pharmacol 2019,14(2),278-294","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","volume":"31","author":"Greene L.A.","year":"2011","unstructured":"Greene L.A.; Levy O.; Malagelada C.; Akt as a victim, villain and potential hero in Parkinson\u2019s disease pathophysiology and treatment. Cell Mol Neurobiol 2011,31(7),969-978","journal-title":"Cell Mol Neurobiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12035-013-8483-x","volume":"49","author":"Niranjan R.","year":"2014","unstructured":"Niranjan R.; The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson\u2019s disease: focus on astrocytes. Mol Neurobiol 2014,49(1),28-38","journal-title":"Mol Neurobiol"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078418","volume":"8","author":"He Q.","year":"2013","unstructured":"He Q.; Yu W.; Wu J.; Intranasal LPS-mediated Parkinson\u2019s model challenges the pathogenesis of nasal cavity and environmental toxins. PLoS One 2013,8(11)","journal-title":"PLoS One"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s12035-013-8586-4","volume":"49","author":"Zhang W.","year":"2014","unstructured":"Zhang W.; Yan Z.F.; Gao J.H.; Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration. Mol Neurobiol 2014,49(3),1153-1165","journal-title":"Mol Neurobiol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","volume":"37","author":"Singh S.S.","year":"2019","unstructured":"Singh S.S.; Rai S.N.; Birla H.; Zahra W.; Rathore A.S.; Singh S.P.; NF-\u03baB-mediated neuroinflammation in Parkinson\u2019s disease and potential therapeutic effect of polyphenols. Neurotox Res 2019,37(3),491-507","journal-title":"Neurotox Res"},{"key":"ref=74","first-page":"1865","volume":"14","author":"Yao K.","year":"2008","unstructured":"Yao K.; Zhang L.; Zhang Y.; Ye P.; Zhu N.; The flavonoid, fisetin, inhibits UV radiation-induced oxidative stress and the activation of NF-kappaB and MAPK signaling in human lens epithelial cells. Mol Vis 2008,14,1865-1871","journal-title":"Mol Vis"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s13105-015-0412-1","volume":"71","author":"Al-Rasheed N.M.","year":"2015","unstructured":"Al-Rasheed N.M.; Al-Rasheed N.M.; Bassiouni Y.A.; Vitamin D attenuates pro-inflammatory TNF-\u03b1 cytokine expression by inhibiting NF-\u043aB\/p65 signaling in hypertrophied rat hearts. J Physiol Biochem 2015,71(2),289-299","journal-title":"J Physiol Biochem"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/713517","volume":"2011","author":"Litteljohn D.","year":"2010","unstructured":"Litteljohn D.; Mangano E.; Clarke M.; Bobyn J.; Moloney K.; Hayley S.; Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinsons Dis 2010,2011","journal-title":"Parkinsons Dis"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","volume":"341","author":"Sherer T.B.","year":"2003","unstructured":"Sherer T.B.; Betarbet R.; Kim J.H.; Greenamyre J.T.; Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease. Neurosci Lett 2003,341(2),87-90","journal-title":"Neurosci Lett"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.neuroscience.2012.11.006","volume":"231","author":"Thakur P.","year":"2013","unstructured":"Thakur P.; Nehru B.; Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson\u2019s disease. Neuroscience 2013,231,420-431","journal-title":"Neuroscience"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fphar.2018.00757","volume":"9","author":"Singh S.S.","year":"2018","unstructured":"Singh S.S.; Rai S.N.; Birla H.; Effect of chlorogenic acid supplementation in MPTP-intoxicated mouse. Front Pharmacol 2018,9,757","journal-title":"Front Pharmacol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","volume":"10","author":"Yan J.","year":"2014","unstructured":"Yan J.; Fu Q.; Cheng L.; Inflammatory response in Parkinson\u2019s disease. (review) Mol Med Rep 2014,10(5),2223-2233","journal-title":"Mol Med Rep"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"Johnson M.E.","year":"2015","unstructured":"Johnson M.E.; Bobrovskaya L.; An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology 2015,46,101-116","journal-title":"Neurotoxicology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/15376516.2017.1333553","volume":"27","author":"Jiang X.W.","year":"2017","unstructured":"Jiang X.W.; Qiao L.; Feng X.X.; Rotenone induces nephrotoxicity in rats: oxidative damage and apoptosis. Toxicol Mech Methods 2017,27(7),528-536","journal-title":"Toxicol Mech Methods"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuron.2009.12.030","volume":"65","author":"Surmeier D.J.","year":"2010","unstructured":"Surmeier D.J.; \u03b1-Synuclein at the synaptic gate. Neuron 2010,65(1),3-4","journal-title":"Neuron"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","volume":"62","author":"Sanders L.H.","year":"2013","unstructured":"Sanders L.H.; Timothy Greenamyre J.; Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med 2013,62,111-120","journal-title":"Free Radic Biol Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1007\/s12035-016-0028-7","volume":"54","author":"Michel H.E.","year":"2017","unstructured":"Michel H.E.; Tadros M.G.; Esmat A.; Khalifa A.E.; Abdel-Tawab A.M.; Tetramethylpyrazine ameliorates rotenone-induced Parkinson\u2019s disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions. Mol Neurobiol 2017,54(7),4866-4878","journal-title":"Mol Neurobiol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.toxlet.2016.11.002","volume":"265","author":"Zhang Q.S.","year":"2017","unstructured":"Zhang Q.S.; Heng Y.; Yuan Y.H.; Chen N.H.; Pathological \u03b1-synuclein exacerbates the progression of Parkinson\u2019s disease through microglial activation. Toxicol Lett 2017,265,30-37","journal-title":"Toxicol Lett"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"Goedert M.","year":"2013","unstructured":"Goedert M.; Spillantini M.G.; Del Tredici K.; Braak H.; 100 years of Lewy pathology. Nat Rev Neurol 2013,9(1),13-24","journal-title":"Nat Rev Neurol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbrc.2016.09.109","volume":"479","author":"Hoffmann A.","year":"2016","unstructured":"Hoffmann A.; Ettle B.; Bruno A.; Alpha-synuclein activates BV2 microglia dependent on its aggregation state. Biochem Biophys Res Commun 2016,479(4),881-886","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","volume":"36","author":"Jiang T.","year":"2015","unstructured":"Jiang T.; Hoekstra J.; Heng X.; P2X7 receptor is critical in \u03b1-synuclein--mediated microglial NADPH oxidase activation. Neurobiol Aging 2015,36(7),2304-2318","journal-title":"Neurobiol Aging"},{"key":"ref=90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162717","volume":"11","author":"Hoenen C.","year":"2016","unstructured":"Hoenen C.; Gustin A.; Birck C.; Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant. PLoS One 2016,11(9)","journal-title":"PLoS One"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"Zhang W.","year":"2005","unstructured":"Zhang W.; Wang T.; Pei Z.; Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 2005,19(6),533-542","journal-title":"FASEB J"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mcn.2013.09.002","volume":"57","author":"Wright J.A.","year":"2013","unstructured":"Wright J.A.; McHugh P.C.; Pan S.; Cunningham A.; Brown D.R.; Counter-regulation of alpha- and beta-synuclein expression at the transcriptional level. Mol Cell Neurosci 2013,57,33-41","journal-title":"Mol Cell Neurosci"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184816\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:51:00Z","timestamp":1626961860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184816\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":92,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,11,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527319666200812224457","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}